Jim Simons’s Enzymotec Ltd ENZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-642,700
Closed -$7.62M 3754
2017
Q4
$7.62M Buy
642,700
+264,200
+70% +$3.07M 0.01% 1548
2017
Q3
$4.33M Buy
378,500
+79,500
+27% +$784K 0.01% 1858
2017
Q2
$2.42M Buy
299,000
+10,300
+4% +$85.8K ﹤0.01% 2149
2017
Q1
$2.54M Sell
288,700
-1,300
-0.4% -$11K ﹤0.01% 2108
2016
Q4
$1.9M Buy
290,000
+31,700
+12% +$209K ﹤0.01% 2260
2016
Q3
$1.81M Buy
258,300
+17,300
+7% +$139K ﹤0.01% 2248
2016
Q2
$2.02M Buy
241,000
+60,000
+33% +$497K ﹤0.01% 2192
2016
Q1
$1.63M Sell
181,000
-36,700
-17% -$320K ﹤0.01% 2339
2015
Q4
$2.13M Buy
217,700
+71,700
+49% +$679K ﹤0.01% 2068
2015
Q3
$1.32M Buy
146,000
+63,506
+77% +$567K ﹤0.01% 2231
2015
Q2
$689K Buy
82,494
+28,294
+52% +$260K ﹤0.01% 2618
2015
Q1
$390K Buy
+54,200
New +$383K ﹤0.01% 2685

Jim Simons's ENZY Position: Q1 2018 in Review

Jim Simons sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 642,700 shares — an estimated $7.62M sold.

Jim Simons first reported a position in ENZY in Q1 2015 and held it in 12 quarters. The position peaked at $7.62M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

  • Jim Simons reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
  • Jim Simons sold 642,700 Enzymotec Ltd shares in Q1 2018, an estimated $7.62M.
  • Jim Simons first reported a position in Enzymotec Ltd in Q1 2015 and held it in 12 quarters.
  • Jim Simons's Enzymotec Ltd position peaked at $7.62M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.